Completed PHASE1/PHASE2 INTERVENTIONAL 4-arm NCT01133899

Guanidinoacetic Acid (GAA) Administration in Physically Active Men and Women

The Effects of Medium-term Oral Guanidinoacetic Acid (GAA) Administration on Human Performance, Body Composition, and Metabolic Outcomes in Physically Active Men and Women

Sponsor: Metropolitan University, Serbia

Conditions Athletic Performance

Interventions GAA-1 GAA-4 PLACEBO guanidinoacetic acid

Updated 5 times since 2017 Last updated: Dec 18, 2011 Started: Mar 31, 2010 Primary completion: Dec 31, 2011 Completion: Dec 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Athletic Performance, this trial is completed. The trial is conducted by Metropolitan University, Serbia and has accumulated 5 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Mar 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Metropolitan University, Serbia

Data source: Metropolitan University, Serbia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Novi Sad, Serbia